Applied Fundamental Research in Surgery Prize – November 28, 2025

This awarded stands for her groundbreaking contribution to research on chemotherapy resistance in hepatoblastoma, the most common pediatric liver cancer. She contribitutes to identify that blocking ATR with the drug elimusertib, combined with cisplatin, significantly reduces tumor growth in cisplatin-resistant cases, offering a promising new treatment approach for children who don’t respond to standard therapy.
See the full article

Eligibility: Surgeons, interventional physicians, and anesthesiologists (for the Surgical Risk Prevention Prize only) under 40 years old in the year of application. Primarily targets surgeons completing their Master 2 year and those pursuing doctoral studies, though not exclusively.

Award Criteria: Recognizes the best laboratory research work. All aspects of surgical laboratory research are eligible, including biology, oncology, regenerative medicine, genetics, and more.